Searle & Co’s Merck MRK Stock Holding History

Searle & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.39M	Hold	53,163	–	–	1.61%	19
2025 Q4	$5.6M	Buy	53,163 +918	+2%	+$86.2K	1.44%	19
2025 Q3	$4.38M	Sell	52,245 -1,029	-2%	-$84.8K	1.16%	26
2025 Q2	$4.22M	Sell	53,274 -1,400	-3%	-$111K	1.19%	24
2025 Q1	$4.91M	Buy	54,674 +809	+2%	+$75.5K	1.4%	21
2024 Q4	$5.36M	Buy	53,865 +12,472	+30%	+$1.29M	1.54%	18
2024 Q3	$4.7M	Sell	41,393 -22,928	-36%	-$2.72M	1.17%	19
2024 Q2	$7.96M	Buy	64,321 +6,447	+11%	+$830K	1.87%	11
2024 Q1	$7.64M	Hold	57,874	–	–	1.95%	10
2023 Q4	$6.31M	Buy	57,874 +21,184	+58%	+$2.2M	1.73%	14
2023 Q3	$3.78M	Hold	36,690	–	–	1.29%	22
2023 Q2	$3.91M	Hold	36,690	–	–	1.21%	24
2023 Q1	$4.24M	Sell	36,690 -216	-0.6%	-$23.3K	1.39%	22
2022 Q4	$4.09M	Hold	36,906	–	–	1.4%	22
2022 Q3	$3.18M	Hold	36,906	–	–	1.22%	25
2022 Q2	$3.37M	Buy	36,906 +2,000	+6%	+$177K	1.33%	26
2022 Q1	$2.86M	Buy	34,906 +300	+0.9%	+$23.7K	1.06%	32
2021 Q4	$2.65M	Hold	34,606	–	–	0.96%	37
2021 Q3	$2.6M	Buy	34,606 +9,621	+39%	+$732K	1.06%	34
2021 Q2	$1.94M	Sell	24,985 -1,199	-5%	-$89.2K	0.79%	48
2021 Q1	$1.93M	Hold	26,184	–	–	0.86%	44
2020 Q4	$2.04M	Buy	26,184 +209	+0.8%	+$16K	0.98%	38
2020 Q3	$2.06M	Buy	25,975 +786	+3%	+$61.6K	1.12%	32
2020 Q2	$1.86M	Buy	25,189 +262	+1%	+$19.7K	1.08%	33
2020 Q1	$1.83M	Hold	24,927	–	–	1.3%	27
2019 Q4	$2.16M	Sell	24,927 -24	-0.1%	-$1.97K	1.19%	31
2019 Q3	$2M	Hold	24,951	–	–	1.18%	31
2019 Q2	$2M	Hold	24,951	–	–	1.21%	30
2019 Q1	$1.98M	Hold	24,951	–	–	1.23%	31
2018 Q4	$1.82M	Hold	24,951	–	–	1.28%	29
2018 Q3	$1.69M	Sell	24,951 -524	-2%	-$33.4K	0.99%	37
2018 Q2	$1.48M	Hold	25,475	–	–	0.94%	38
2018 Q1	$1.32M	Sell	25,475 -105	-0.4%	-$5.67K	0.86%	40
2017 Q4	$1.37M	Buy	25,580 +275	+1%	+$15.2K	0.86%	39
2017 Q3	$1.55M	Hold	25,305	–	–	1.02%	35
2017 Q2	$1.55M	Sell	25,305 -2,044	-7%	-$124K	1.06%	36
2017 Q1	$1.66M	Hold	27,349	–	–	1.16%	29
2016 Q4	$1.54M	Buy	27,349 +210	+0.8%	+$12.3K	1.27%	24
2016 Q3	$1.62M	Buy	+27,139	New	+$1.59M	1.41%	18
2016 Q2	–	Sell	-27,139	Closed	-$1.39M	–	71
2016 Q1	$1.39M	Hold	27,139	–	–	1.28%	25
2015 Q4	$1.36M	Buy	27,139 +560	+2%	+$28.2K	1.3%	22
2015 Q3	$1.25M	Hold	26,579	–	–	1.29%	23
2015 Q2	$1.44M	Hold	26,579	–	–	1.2%	23
2015 Q1	$1.46M	Hold	26,579	–	–	1.25%	20
2014 Q4	$1.44M	Buy	+26,579	New	+$1.48M	1.22%	18

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Searle & Co's MRK Position: Q1 2026 in Review

Searle & Co held its Merck (MRK) position steady in Q1 2026 at 53,163 shares worth $6.39M. The position accounts for 1.61% of the portfolio, ranked #19.

Searle & Co first reported a position in MRK in Q4 2014 and has held it in 45 quarters since. The position peaked at $7.96M in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Searle & Co held 53,163 shares of Merck worth $6.39M as of Q1 2026.
Searle & Co left its Merck share count unchanged in Q1 2026.
Merck made up 1.61% of Searle & Co's portfolio in Q1 2026, its #19 holding.
Searle & Co first reported a position in Merck in Q4 2014 and has held it in 45 quarters since.
Searle & Co's Merck position peaked at $7.96M in Q2 2024.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Searle & Co's 13F filing for Q1 2026, filed 8 May 2026.